ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...

The ViaLase Laser combines the precision of femtosecond laser technology and the accuracy of micron-level image guidance to deliver the world's first femtosecond laser image-guided high-precision ...

Please provide your email address to receive an email when new articles are posted on . Femtosecond laser image-guided high-precision trabeculotomy, or FLigHT, for primary open-angle glaucoma showed ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

DEAR DR. ROACH: My eye doctor told me I’m in danger of an “acute attack” of narrow angle glaucoma and that I need iridotomy in both eyes right away. He also said this may be related to my headaches. I ...

Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...

More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...

Dear Dr. Roach: My eye doctor told me I’m in danger of an “acute attack” of narrow angle glaucoma and that I need iridotomy in both eyes right away. He also said this may be related to my headaches. I ...